+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Fatal central nervous system disease in lymphocytic choriomeningitis virus carrier mice given lymphocytic choriomeningitis virus immune donor spleen cells



Fatal central nervous system disease in lymphocytic choriomeningitis virus carrier mice given lymphocytic choriomeningitis virus immune donor spleen cells



Federation Proceedings 30(2): 353




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 026625835

Download citation: RISBibTeXText


Related references

Immunopathogenesis Of Acute Central Nervous System Disease Produced By Lymphocytic Choriomeningitis Virus: I. Cyclophosphamide-Mediated Induction Of The Virus-Carrier State In Adult Mice. Journal of Experimental Medicine 135(4): 860-873, 1972

Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice. Journal of Experimental Medicine 135(4): 860-873, 1972

The lymphocytic choriomeningitis virus infection a virus induced immune disease of the developing nervous system. Journal of Cell Biology 59(2 PT 2): 76, 1973

Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. II. Relationship of the anti-lymphocytic choriomeningitis immune response to tissue injury in chronic lymphocytic choriomeningitis disease. Journal of Experimental Medicine 131(1): 1-19, 1970

Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature 238(5363): 335-337, 1972

CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system. Journal of Immunology 176(7): 4235-4243, 2006

Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: role of the H-2 region in determining cross-reactivity for different lymphocytic choriomeningitis virus strains. Journal of Virology 51(1): 34-41, 1984

Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers. Journal of Experimental Medicine 135(4): 874-889, 1972

Ultrastructure of the lymphocytic choriomeningitis virus infection in the rat an immune disease of the developing nervous system. Anatomical Record 175(2): 304, 1973

Lymphocytic choriomeningitis virus glycoprotein expressed in vaccinia virus allows h 2 restricted lymphocytic choriomeningitis virus specific cytotoxic t lymphocyte recognition lysis. Federation Proceedings 45(4): 979, 1986

Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease. Federation Proceedings 30(6): 1831-1841, 1971

Nature of the inflammatory process in the central nervous system of mice infected with lymphocytic choriomeningitis virus. Current Topics in Microbiology and Immunology 134: 131-143, 1987

Cyto toxic t lymphocyte clones induced by lymphocytic choriomeningitis virus reactivity for lymphocytic choriomeningitis virus strains and major histo compatibility complex antigens. Federation Proceedings 42(5): ABSTRACT 6333, 1983

Lymphocytic choriomeningitis virus-induced disease of the central nervous system and the "antigen-sink" hypothesis. Medical Microbiology and Immunology 175(2-3): 205-208, 1986

Prevalence of lymphocytic choriomeningitis virus antibodies in patients with acute central nervous system disease. Journal of Infection 5(3): 309-310, 1982